Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways.
Elife. 2015 Feb 16;4:e06132. doi: 10.7554/eLife.06132.
Elife. 2015.
PMID: 25686219
Free PMC article.
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.
Turke AB, Zejnullahu K, Wu YL, Song Y, Dias-Santagata D, Lifshits E, Toschi L, Rogers A, Mok T, Sequist L, Lindeman NI, Murphy C, Akhavanfard S, Yeap BY, Xiao Y, Capelletti M, Iafrate AJ, Lee C, Christensen JG, Engelman JA, Jänne PA.
Turke AB, et al.
Cancer Cell. 2010 Jan 19;17(1):77-88. doi: 10.1016/j.ccr.2009.11.022.
Cancer Cell. 2010.
PMID: 20129249
Free PMC article.
Item in Clipboard
PIKing the right patient.
Turke AB, Engelman JA.
Turke AB, et al.
Clin Cancer Res. 2010 Jul 15;16(14):3523-5. doi: 10.1158/1078-0432.CCR-10-1201. Epub 2010 Jun 10.
Clin Cancer Res. 2010.
PMID: 20538763
Item in Clipboard
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib.
Corcoran RB, Ebi H, Turke AB, Coffee EM, Nishino M, Cogdill AP, Brown RD, Della Pelle P, Dias-Santagata D, Hung KE, Flaherty KT, Piris A, Wargo JA, Settleman J, Mino-Kenudson M, Engelman JA.
Corcoran RB, et al. Among authors: turke ab.
Cancer Discov. 2012 Mar;2(3):227-35. doi: 10.1158/2159-8290.CD-11-0341. Epub 2012 Jan 16.
Cancer Discov. 2012.
PMID: 22448344
Free PMC article.
Item in Clipboard
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, Akhavanfard S, Heist RS, Temel J, Christensen JG, Wain JC, Lynch TJ, Vernovsky K, Mark EJ, Lanuti M, Iafrate AJ, Mino-Kenudson M, Engelman JA.
Sequist LV, et al. Among authors: turke ab.
Sci Transl Med. 2011 Mar 23;3(75):75ra26. doi: 10.1126/scitranslmed.3002003.
Sci Transl Med. 2011.
PMID: 21430269
Free PMC article.
Item in Clipboard
MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors.
Turke AB, Song Y, Costa C, Cook R, Arteaga CL, Asara JM, Engelman JA.
Turke AB, et al.
Cancer Res. 2012 Jul 1;72(13):3228-37. doi: 10.1158/0008-5472.CAN-11-3747. Epub 2012 May 2.
Cancer Res. 2012.
PMID: 22552284
Free PMC article.
Item in Clipboard
Using tandem mass spectrometry in targeted mode to identify activators of class IA PI3K in cancer.
Yang X, Turke AB, Qi J, Song Y, Rexer BN, Miller TW, Jänne PA, Arteaga CL, Cantley LC, Engelman JA, Asara JM.
Yang X, et al. Among authors: turke ab.
Cancer Res. 2011 Sep 15;71(18):5965-75. doi: 10.1158/0008-5472.CAN-11-0445. Epub 2011 Jul 20.
Cancer Res. 2011.
PMID: 21775521
Free PMC article.
Item in Clipboard
A Cross-Species Study of PI3K Protein-Protein Interactions Reveals the Direct Interaction of P85 and SHP2.
Breitkopf SB, Yang X, Begley MJ, Kulkarni M, Chiu YH, Turke AB, Lauriol J, Yuan M, Qi J, Engelman JA, Hong P, Kontaridis MI, Cantley LC, Perrimon N, Asara JM.
Breitkopf SB, et al. Among authors: turke ab.
Sci Rep. 2016 Feb 3;6:20471. doi: 10.1038/srep20471.
Sci Rep. 2016.
PMID: 26839216
Free PMC article.
Item in Clipboard
Cite
Cite